Literature DB >> 17557215

Patient self-management of long-term oral anticoagulation in Switzerland.

Jordan Fritschi1, Pascale Raddatz-Müller, Pirmin Schmid, Walter A Wuillemin.   

Abstract

Indications for oral anticoagulation (OAC) have increased in recent years. OAC requires frequent monitoring of the prothrombin time to keep the intensity within the therapeutic range and to minimise the risk for complications. Patient self-management (PSM) has been found to improve the quality of OAC. The present study aimed to investigate the first 330 patients performing PSM in Switzerland. A questionnaire was sent to all patients who followed a teaching program for PSM of OAC between 1998 and 2003. Moreover, family physicians were contacted and/or discharge letters were obtained from the hospitals or the treating physicians. During the study period 13 patients died. Out of the 300 patients providing information 254 (85%) still perform PSM. At least one INR determination per two weeks was done by 74% of the patients and 25% performed at least one INR measurement every 15-30 days. The median time spent within the individual INR target range was 72%. No thromboembolic complications occurred, however, among the 13 patients who died, 1 had myocardial infarction and 6 died of heart failure. When counting these events as arterial thromboembolic complications the frequency was 0.6 (95% CI: 0.3-1.3) per 100 patient-years. The frequency of major bleeding was 0.6 (95% CI: 0.2-1.3) per 100 patient-years. We conclude from this study investigating a real-world patient collective that PSM is suitable and safe for the patients identified by their family physicians and successfully trained by our training centre.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17557215     DOI: 2007/17/smw-11766

Source DB:  PubMed          Journal:  Swiss Med Wkly        ISSN: 0036-7672            Impact factor:   2.193


  4 in total

1.  Sex differences in treatment quality of self-managed oral anticoagulant therapy: 6,900 patient-years of follow-up.

Authors:  Hanna Nilsson; Erik Lerkevang Grove; Torben Bjerregaard Larsen; Peter Brønnum Nielsen; Flemming Skjøth; Marianne Maegaard; Thomas Decker Christensen
Journal:  PLoS One       Date:  2014-11-21       Impact factor: 3.240

2.  Should we test the prothrombin time in anticoagulated epistaxis patients?

Authors:  Michael B Soyka; David Holzmann
Journal:  Allergy Rhinol (Providence)       Date:  2013

3.  Patient self-management of oral anticoagulation with vitamin K antagonists in everyday practice: efficacy and safety in a nationwide long-term prospective cohort study.

Authors:  Michael Nagler; Lucas M Bachmann; Pirmin Schmid; Pascale Raddatz Müller; Walter A Wuillemin
Journal:  PLoS One       Date:  2014-04-18       Impact factor: 3.240

4.  Long-term effectiveness and safety of self-management of oral anticoagulants in real-world settings.

Authors:  Bárbara Menéndez-Jándula; José Antonio García-Erce; Clara Zazo; Luis Larrad-Mur
Journal:  BMC Cardiovasc Disord       Date:  2019-08-02       Impact factor: 2.298

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.